Long‐Term Effects of Glucosamine and Chondroitin Sulfate on the Progression of Structural Changes in Knee Osteoarthritis: Six‐Year Followup Data From the Osteoarthritis Initiative
Open Access
- 16 February 2016
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 68 (10) , 1560-1566
Abstract
Objective: To examine the long‐term (6‐year) effect of combined glucosamine (Glu) and chondroitin sulfate (CS) treatment on cartilage volume in knee osteoarthritis (OA).Methods: Participants were from the Osteoarthritis Initiative progression and incidence subcohorts, had magnetic resonance imaging (MRI) of the target knee at baseline and 6 years, joint space width >1 mm, and data available on Glu/CS consumption (n = 1,593). They were stratified into 2 main groups based on whether or not they had medial meniscal extrusion at baseline. The group with meniscal extrusion (n = 429) was further stratified into subgroups based on exposure or no exposure to Glu/CS as follows: not exposed, 1 year, 2–3 years, and 4–6 years. Cartilage volume was assessed using fully automated quantitative MRI technology.Results: The Jonckheere‐Terpstra trend test indicated that treatment with Glu/CS significantly reduced the cartilage volume loss in the global knee, associated with the lateral compartment. Multivariate analysis further demonstrated that the extent of the treatment's positive effect was related to exposure time to treatment, the protective effect at 6 years being significant in participants exposed to ≥2 years of treatment.Conclusion: These findings provide future support for the long‐term protective structure‐modifying effects of Glu/CS treatment in knee OA subjects.Keywords
Funding Information
- Bioiberica (Barcelona, Spain), the Osteoarthritis Research Unit and the Chair in Osteoarthritis of the University of Montreal (Montreal, Quebec, Canada)
This publication has 19 references indexed in Scilit:
- Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohortSeminars in Arthritis and Rheumatism, 2015
- Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimensAnnals of the Rheumatic Diseases, 2015
- First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohortAnnals of the Rheumatic Diseases, 2015
- A fully automated human knee 3D MRI bone segmentation using the ray casting techniqueMedical & Biological Engineering & Computing, 2011
- Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysisBMJ, 2010
- Automatic Human Knee Cartilage Segmentation From 3-D Magnetic Resonance ImagesIEEE Transactions on Biomedical Engineering, 2010
- Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year durationOsteoarthritis and Cartilage, 2010
- The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfateCurrent Medical Research and Opinion, 2008
- Glucosamine for pain in osteoarthritis: Why do trial results differ?Arthritis & Rheumatism, 2007
- Glucosamine and Chondroitin for Treatment of OsteoarthritisJAMA, 2000